To prohibit further action on the proposed rule regarding testing of Medicare part B prescription drug models.

Fact Sheet API

Bill Number

HR 5122

Introduced

Apr 29, 2016

Latest Action

Referred to the Subcommittee on Health.

Sponsor

Cosponsors

Topics

Administrative law and regulatory procedures Department of Health and Human Services Drug therapy Health Medicare Prescription drugs

Full Text

View Full Bill Text

Votes

Summary

This bill prohibits the Department of Health and Human Services from taking any further action on a proposed rule to change how Medicare pays for certain drugs that are typically not self-administered (such as some intravenous medications and chemotherapy drugs).

Actions

May 12, 2016

Referred to the Subcommittee on Health.
May 6, 2016

Referred to the Subcommittee on Health.
Apr 29, 2016

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Apr 29, 2016

Introduced in House

Amendments

Related Bills